Searched for
EBITDA POSITIVE
Temasek, ChrysCap brew up plans for Blue Tokai stake, put Rs 1000-1200 crore on the tableThe deal will value Blue Tokai chain at up to Rs 3,700 crore. This will be the largest round for the roasters so far, and will involve a co...- Ather expects mass-market Konarc e-scooter to deliver higher margins than Rizta within a year: CEO Tarun MehtaAther Energy expects its new Konarc electric scooter to deliver higher gross margins than the Rizta within a year, CEO Tarun Mehta told ET....
- HSBC initiates coverage on this recently listed healthcare stock that can rally up to 26%. Do you own?HSBC has initiated coverage on recently listed Manipal Health with a Buy rating and Rs 1,000 target price, implying 26% upside. The brokera...
- Weddings, leisure and corporate comeback put India’s hotels on a stronger H2 path: ReportIndia's hotel sector anticipates stronger growth in the latter half of FY27. Robust domestic leisure demand and recovering corporate travel...
- Tempsens Instruments doubles IPO investors’ money as stock lists at 111% premium. Should you buy, sell or hold?Tempsens Instruments made a blockbuster debut, listing at Rs 634 on the NSE, an 111% premium over its Rs 300 IPO price. The stock briefly g...
- Vodafone Idea plans to repay ₹49,000 crore spectrum dues in 3 yearsVodafone Idea plans to pay nearly ₹49,000 crore in spectrum dues over the next three years, with payments of about ₹7,000 crore in FY27, ₹1...
- Motilal Oswal initiates coverage on Adani Enterprises with Buy, sees 25% upside. Here’s whyMotilal Oswal has initiated coverage on Adani Enterprises with a Buy rating and a target price of Rs 3,880, implying 25% upside from the pr...
- Ventura initiates coverage on Meesho and LG India, sees up to 35% upsideVentura Securities has initiated coverage on Meesho and LG Electronics India with Buy ratings, seeing up to 35% upside. The brokerage expec...
- M&A deals double, but execution holds the key for investors: Crisil RatingsIndia Inc’s annual M&A volumes have more than doubled since fiscal 2017 as companies pursue faster growth, market expansion and new capabil...
- M&A deals more than double as India Inc steps up growth bets: CrisilIndian companies are increasingly using mergers and acquisitions to accelerate growth. Deal volumes have more than doubled since fiscal 201...
- MTAR Tech shares rally 3%, extend gains for second session. What’s triggering the surge?MTAR Technologies shares gained 3% after the company secured a Rs 127 crore order from Nuclear Power Corporation of India for coolant chann...
- Buy, Sell or Hold: Antique initiates coverage on Astra Microwave Products; Goldman Sachs recommends Buy on Indian HotelsTop brokerages have flagged upside in PB Fintech, Astra Microwave Products and Indian Hotels Company, with Bernstein retaining an Outperfor...
- ETMarkets Management Talk| EPL’s growth story enters next gear: High-teens guidance, 20% margins and Indovida merger, explains CEO Hemant BakshiStrong momentum in Beauty & Cosmetics, a recovery in Oral Care and the ramp-up of its Thailand operations are expected to support growth, w...
- Can Symbiotec Pharmalab IPO deliver long-term growth for high-risk investors?Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...
- Metals sector outlook improves as non-ferrous earnings lead recovery: SystematixIndia's metals and mining sector outlook is improving significantly. Non-ferrous companies are expected to lead earnings growth and perform...
- Aditya Infotech shares can rally up to 27%? Why Motilal Oswal initiated coverage on the stockMotilal Oswal sees 27% upside in Aditya Infotech, citing strong surveillance demand, rising market share, STQC norms and improving margins....
- Buy, Sell or Hold: Motilal Oswal maintains buy on Crompton Greaves; Elara Capital recommends buy on ArvindBrokerages remain bullish on Arvind, Bajaj Finance and Crompton Greaves Consumer Electricals, citing growth opportunities, earnings recover...
- Pharmeasy-parent’s loss narrows in Q1, revenue up 10%API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while reven...
- Jefferies raises Emmvee Photovoltaic Power target price to Rs 440: Can the stock rally further?Jefferies has raised its target price for Emmvee Photovoltaic Power to Rs 440 from Rs 400, while retaining its Buy rating, implying around ...
- Buy, Sell or Hold: Nomura maintains neutral stance on Maruti Suzuki; Goldman Sachs recommends buy on Godrej ConsumerTop global brokerages have issued fresh calls across sectors. Nomura maintained Neutral on Maruti Suzuki expecting further price hikes, whi...
Load More
